Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution
Se. Kuhmann et al., Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution, J VIROLOGY, 75(18), 2001, pp. 8449-8460
In contrast to humans, several primate species are believed to have harbore
d simian immunodeficiency viruses (SIVs) since ancient times. In particular
, the geographically dispersed species of African green monkeys (AGMs) are
all infected with highly diversified SIVagm viruses at high prevalences (gr
eater than 50% of sexually mature individuals) without evident diseases, im
plying that the progenitor monkeys were infected prior to their dispersal.
If this is correct, AGMs would be expected to have accumulated frequent res
istance-conferring polymorphisms in host genes that are important for SIV r
eplication. Accordingly, we analyzed the coding sequences of the CCR5 corec
eptors from 26 AGMs (52 alleles) in distinct populations of the four specie
s. These samples contained 29 nonsynonymous coding changes and only 15 syno
nymous nucleotide substitutions, implying intense functional selection. Mor
eover, 24 of the resulting amino acid substitutions were tightly clustered
in the CCR5 amino terminus (D13N in the vervets and Y14N in the tantalus sp
ecies) or in the first extracellular loop (Q93R and Q93K in all species). T
he Y14N substitution was extremely frequent in the 12 wild-born African tan
talus, with 7 monkeys being homozygous for this substitution and 4 being he
terozygous. Although two of these heterozygotes and the only wild-type homo
zygote were naturally infected with SIVagm, none of the Y14N homozygotes we
re naturally infected. A focal infectivity assay for SIVagm indicated that
all five tested SIVagms efficiently use CCR5 as a coreceptor and that they
also use CXCR6 (STRL33/Bonzo) and GPR15 (BOB) with lower efficiencies but n
ot CXCR4. Interestingly, the D13N, Y14N, Q93R, and Q93K substitutions in AG
M CCR5 all strongly inhibited infections by the SIVagm, isolates in vitro.
The Y14N substitution eliminates a tyrosine sulfation site that is importan
t for infections and results in partial N-linked glycosylation (i.e., 60% e
fficiency) at this position. Nevertheless, the CCR5(Y14N) component that la
cks an N-linked oligosaccharide binds the chemokine MIP-1 beta with a norma
l affinity and is fully active in signal transduction. Similarly, D13N and
Q93R substitutions did not interfere with signal transduction. Thus, the co
mmon substitution polymorphisms in AGM CCR5 strongly inhibit SIVagm infecti
ons while substantially preserving chemokine signaling. In contrast, polymo
rphisms of human CCR5 are relatively infrequent, and the amino acid substit
utions are randomly situated and generally without effects on coreceptor fu
nction. These results support an ancient coevolution of AGMs and SIVagm vir
uses and establish AGMs as a highly informative model for learning about ho
st proteins that play critical roles in immunodeficiency virus infections.